DEA Takes Comments On Kratom, But Keeps Eye On Scheduling
This article was originally published in The Rose Sheet
DEA will accept comments through Dec. 1 on its proposal to move the active materials in kratom into Schedule I under CSA to avoid an imminent hazard to public safety.
You may also be interested in...
FDA states in Federal Register notice that WHO has requested information on whether kratom – mitragynine, 7-hydroxymitragynine – should be added to the United Nations’ schedule of controlled substances.
Former commissioner Scott Gottlieb and former HHS health chief Brett Giroir make clear they haven’t changed their minds in Twitter posts following FDA kratom seizure announcement.
HHS released to industry proponents Reps. Mark Pocan and Morgan Griffith the letter it submitted in 2018 notifying DEA that it was rescinding recommendation it made in 2017 to list kratom active ingredients mitragynine and 7-hydroxymitragynine under Schedule I of the CSA.